Review
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1135-1148
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1135
Table 2 The role of ferroptosis in colorectal cancer
Intervention
Target
Effects and mechanism
Ref.
SRSF9GPX4↓Inhibition of SRSF9 increases erastin-induced iron death by downregulation of GPX4 level[74]
IMCASLC7A11↓IMCA induces SLC7A11 mediated ferroptosis through AMPK/mTOR pathway[77]
TalaAROS↑, SLC7A11↓TalaA induces ferroptosis to kill CRC cells[144]
Lipocalin 2GPX4↑, system Xc−↑Overexpression of Lipocalin 2 inhibits ferroptosis and promotes CRC progression[75]
TIGARGSH↓, ROS↑TIGAR induces ferroptosis resistance in CRC by ROS/AMPK/SCD1 signaling pathway[145]
HIF-2αIron↑HIF-2α activation potentiates oxidative cell death in CRCs by increasing cellular iron[79]
TP53Lipid peroxidation, ACSL4↑Restricts ferroptosis by blocking DPP4 activity in a transcription independent manner TP53[91]
Tagitinin CNRF2/HO-1↑, lipid peroxidationTagitin C activates NRF2/HO-1 pathway to induce ferroptosis[82]
CetuximabNRF2↓, ROS↑Cetuximab inhibits Nrf2/HO-1 pathway to promote ferroptosis in CRC[85]
Beta-elemeneGSH↓, GPX4↓Combined treatment with beta-elemene and cetuximab induces ferroptosis in CRC[96]
Vitamin CIron↑, ROS↑Vitamin C limits CRC resistance to EGFR-targeted therapies[97]
FeOOH NSsH2S↓FeOOH NSs eliminate endogenous H2S to induce ferroptosis[99]